1276. Deputy Ken O'Flynn asked the Minister for Health whether all treatment abroad scheme approvals are processed solely within the National Treatment Abroad Office in Kilkenny; and if not, the circumstances under which applications are referred elsewhere within the HSE. [39172/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Departmental Schemes.
146 questions match, newest first.
1277. Deputy Ken O'Flynn asked the Minister for Health whether the HSE applies different governance or oversight procedures to Treatment Abroad Scheme applications involving experimental, highly specialised or unusually costly procedures. [39173/26]
1280. Deputy Ken O'Flynn asked the Minister for Health whether any dedicated value-for-money review has been conducted in relation to the treatment abroad scheme since 2020; and if so, to provide details of the review, its conclusions and any resulting policy changes. [39182/26]
1281. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health maintains a formal risk register relating to the treatment abroad scheme; and if so, the categories of risk monitored including financial, clinical, governance and patient safety risks. [39183/26]
1282. Deputy Ken O'Flynn asked the Minister for Health whether any external clinical governance framework exists for treatments funded under the treatment abroad scheme; and if not, whether consideration is being given to establishing such a framework. [39184/26]
1284. Deputy Ken O'Flynn asked the Minister for Health whether the Department has examined the establishment of an independent oversight or inspection mechanism for the treatment abroad scheme, comparable to governance arrangements applying in other areas of publicly funded healthcare expenditure. [39186/26]
1285. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken regarding the appropriateness of relying primarily on referring consultants for overseas treatment selection and governance assurance under the treatment abroad scheme. [39187/26]
1286. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the treatment abroad scheme for each year from 2020 to 2026, inclusive, and the proportion of that expenditure subject to formal audit review. [39188/26]
1287. Deputy Ken O'Flynn asked the Minister for Health whether the HSE conducts any comparative benchmarking of treatment costs between different EU or EEA jurisdictions under the treatment abroad scheme; and if she will provide details of the methodology used. [39189/26]
1289. Deputy Ken O'Flynn asked the Minister for Health whether any central register exists recording the total annual cost per treatment category funded under the treatment abroad scheme. [39191/26]
1291. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health has carried out any review assessing whether certain procedures regularly funded abroad under the treatment abroad scheme could be developed domestically within the public health system. [39193/26]
1292. Deputy Ken O'Flynn asked the Minister for Health whether any maximum financial approval thresholds apply under the treatment abroad scheme before additional senior management or Departmental approval is required. [39194/26]
1295. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme is currently subject to any formal risk assessment relating to expenditure growth, cost escalation, or dependency on overseas treatment provision. [39197/26]
1296. Deputy Ken O'Flynn asked the Minister for Health whether any external consultancy, economic review, or health technology assessment has been commissioned in relation to expenditure under the treatment abroad scheme since 2020. [39198/26]
1299. Deputy Ken O'Flynn asked the Minister for Health whether any structured patient follow-up programme exists for persons returning to Ireland following procedures funded under the treatment abroad scheme. [39201/26]
1301. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money framework exists comparing the clinical outcomes and costs associated with overseas procedures funded under the treatment abroad scheme against equivalent treatment pathways domestically. [39203/26]
1302. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any provider-level performance monitoring system in respect of overseas hospitals or clinics receiving treatment abroad scheme referrals. [39204/26]
1303. Deputy Ken O'Flynn asked the Minister for Health whether any formal patient safety governance framework exists specifically governing procedures funded under the treatment abroad scheme. [39205/26]
1306. Deputy Ken O'Flynn asked the Minister for Health whether the absence of structured clinical outcome monitoring under the treatment abroad scheme has been identified on any Departmental or HSE risk register. [39208/26]
1307. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a category-specific expenditure breakdown for procedures funded under the treatment abroad scheme; and if so, whether gender affirmation surgeries are separately identifiable within those records. [39210/26]
1308. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money assessment has been conducted regarding overseas gender affirmation surgeries funded under the treatment abroad scheme since 2020. [39211/26]
1309. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment, governance review or assurance process has been undertaken specifically relating to overseas gender affirmation surgery approvals under the treatment abroad scheme. [39212/26]
1313. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the total annual number of gender affirmation surgery applications approved under the treatment abroad scheme since 2020, by year. [39216/26]
1336. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme maintains any dataset identifying the highest-cost individual referrals funded annually; and if she will provide the ten highest annual individual treatment costs since 2020 in anonymised form. [39341/26]
1337. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central register of high-cost treatment abroad scheme approvals; and if so, the criteria used to classify cases as high-cost. [39345/26]